Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 962 people who get email alerts on BCRX.

Get email alerts on BCRX »

Market Currents

Shares of BioCryst Pharmaceuticals (BCRX) shoot up 11% premarket after the firm announces...

Wednesday, October 5, 2011, 7:38 AM ET
Shares of BioCryst Pharmaceuticals (BCRX) shoot up 11% premarket after the firm announces positive top-line results for a Phase 2 study of its gout treatment that met its main goal.

This Market Current was sent to 962 people who get email alerts on BCRX.

Get email alerts on BCRX »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

Latest Articles

A Tale Of 3 Media Publishers: 1 To Buy, 1 To Avoid, 1 To Hold
4:01 PM • Black Coral Research
Yahoo Wades Into Social Media With Tumblr
3:56 PM • Richard Cox
Regeneron Shareholders Watching Optina Trial Closely
3:56 PM • Tom Welch
Sequenom: Plenty Of Room To Run
3:54 PM • Ravi Jain
Apple Bonds In ETFs: If, When And How?
3:52 PM • Matt Tucker
The Dark Side Of Tesla's Masterful Short Squeeze
3:48 PM • John Petersen
What's Your Exit Strategy?
3:45 PM • David Fabian
OptimizeRx's SampleMD Revolutionizing Prescription Drug Sampling
3:43 PM • Brian Marckx
The Stock Market - Which Side Are You On?
3:39 PM • Gary Tanashian
The Cold, Hard Facts Behind Funding Your Retirement
3:33 PM • Dennis Miller
Macy's: It Is Profitable To Buy 'Off The Rack'
3:33 PM • Mark Piro
Bernanke Signaling The Fed's Power To Control The Economy Is Waning
3:31 PM • Larry Trefz
Perion: A Solid Growth Play
3:31 PM • Kyan Alexander
Apple Must Counter The Intel-Microsoft Threat
3:25 PM • Michael Blair
QE Doesn't Help Target's Same-Store Sales
3:22 PM • Seth Golden

More Latest Articles »